These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 2988323

  • 1. Sub-aggregatory doses of catecholamines prevent prostacyclin-induced inhibition of platelet aggregation.
    Buttrick PM, Forscher CA, Sussman II, Mueller HS.
    Am Heart J; 1985 Jun; 109(6):1258-63. PubMed ID: 2988323
    [Abstract] [Full Text] [Related]

  • 2. Intracellular levels of cyclic AMP and cyclic GMP differentially modify platelet aggregate size in human platelets activated with epinephrine or ADP.
    Qi R, Ozaki Y, Satoh K, Yang LB, Asazuma N, Yatomi Y, Kume S.
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):215-22. PubMed ID: 8856476
    [Abstract] [Full Text] [Related]

  • 3. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
    Krishnamurthi S, Westwick J, Kakkar VV.
    Biochem Pharmacol; 1984 Oct 01; 33(19):3025-35. PubMed ID: 6091666
    [Abstract] [Full Text] [Related]

  • 4. The effects of continuous infusions of prostacyclin-Na (epoprostenol-sodium) on platelet counts, ADP-induced aggregation, and cyclic AMP levels in normal volunteers.
    Reele SB, Miller OV, Spillers C, Gorman RR.
    Prostaglandins; 1983 Aug 01; 26(2):287-302. PubMed ID: 6316420
    [Abstract] [Full Text] [Related]

  • 5. The influence of epinephrine on prostacyclin (PGI2) induced dissociation of ADP aggregated plateletes.
    Rao GH, Reddy KR, White JG.
    Prostaglandins Med; 1980 Jun 01; 4(6):385-97. PubMed ID: 6251492
    [Abstract] [Full Text] [Related]

  • 6. Role of cyclic AMP in the inhibition of human platelet aggregation by quercetin, a flavonoid that potentiates the effect of prostacyclin.
    Beretz A, Stierle A, Anton R, Cazenave JP.
    Biochem Pharmacol; 1982 Nov 15; 31(22):3597-600. PubMed ID: 6295405
    [Abstract] [Full Text] [Related]

  • 7. Comparison of equimolar concentrations of iloprost, prostacyclin, and prostaglandin E1 on human platelet function.
    Fisher CA, Kappa JR, Sinha AK, Cottrell ED, Reiser HJ, Addonizio VP.
    J Lab Clin Med; 1987 Feb 15; 109(2):184-90. PubMed ID: 2433373
    [Abstract] [Full Text] [Related]

  • 8. Reduced platelet aggregation by effects of pentoxifylline on vascular prostacyclin isomerase and platelet cyclic AMP.
    Weithmann KU.
    Gen Pharmacol; 1983 Feb 15; 14(1):161-2. PubMed ID: 6298055
    [Abstract] [Full Text] [Related]

  • 9. Stereostructure activity relationships of catecholamines on human platelet function.
    Ahn CH, Shams G, Schotzinger RL, Miller DD, Feller DR.
    Proc Soc Exp Biol Med; 1990 Jun 15; 194(2):149-56. PubMed ID: 2190233
    [Abstract] [Full Text] [Related]

  • 10. In vitro effects of ethanol on rabbit platelet aggregation, secretion of granule contents, and cyclic AMP levels in the presence of prostacyclin.
    Rand ML, Gross PL, Jakowec DM, Packham MA, Mustard JF.
    Thromb Haemost; 1989 Apr 25; 61(2):254-8. PubMed ID: 2546284
    [Abstract] [Full Text] [Related]

  • 11. A chemically stable analogue, 9 beta-methyl carbacyclin, with similar effects to epoprostenol (prostacyclin, PGI2) in man.
    O'Grady J, Hedges A, Whittle BJ, Al-Sinawi LA, Mekki QA, Burke C, Moody SG, Moti MJ, Hassan S.
    Br J Clin Pharmacol; 1984 Dec 25; 18(6):921-33. PubMed ID: 6085004
    [Abstract] [Full Text] [Related]

  • 12. Prostacyclin (PGI2) inhibits the development in human platelets of ADP and arachidonic acid-induced shape change and procoagulant activity.
    Ehrman ML, Jaffe EA.
    Prostaglandins; 1980 Dec 25; 20(6):1103-16. PubMed ID: 7010448
    [Abstract] [Full Text] [Related]

  • 13. Enhancement of the antiaggregatory activity of prostacyclin by propranolol in human platelets.
    Callahan KS, Johnson AR, Campbell WB.
    Circulation; 1985 Jun 25; 71(6):1237-46. PubMed ID: 2986877
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. 6-keto-prostaglandin E1 is not equipotent to prostacyclin (PGI2) as an antiaggregatory agent.
    Miller OV, Aiken JW, Shebuski RJ, Gorman RR.
    Prostaglandins; 1980 Aug 25; 20(2):391-400. PubMed ID: 6251513
    [Abstract] [Full Text] [Related]

  • 20. Prostacyclin inhibits mobilisation of fibrinogen-binding sites on human ADP- and thrombin-treated platelets.
    Hawiger J, Parkinson S, Timmons S.
    Nature; 1980 Jan 10; 283(5743):195-7. PubMed ID: 6985716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.